Your Location：
Home >
Browse articles >
Guizhi Fulingwan Alleviate Hepatic Fibrosis by Modulating mtDNA/NLRP3/Caspase-1/GSDMD Signaling Pathway
Guizhi Fulingwan Alleviate Hepatic Fibrosis by Modulating mtDNA/NLRP3/Caspase-1/GSDMD Signaling Pathway
Enhanced Publication- Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 14, Pages: 91-99(2026)
DOI： 10.13422/j.cnki.syfjx.20252001
Revised：2025-08-14 ，
Accepted：02 September 2025
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 3 ) Tabs( 5 )
References
Publication Info
Metrics
130
Views
86
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Predicting Hepatic Fibrosis Risk in Wilson's Disease： Development and Validation of Prognostic Model Integrating TCM Syndromes and Modern Biomarkers
Mechanism of Qinggan Jianpi Huoxue Prescription Against Hepatic Fibrosis via FoxO1 Mediated Regulation of Glycolytic Metabolic Reprogramming of Hepatic Stellate Cells
Effect of Apaf1-mediated Apoptosis/Pyroptosis on Lipid Deposition in Hepatocytes and Intervention Effect of Ditantang
Staged Treatment of Hepatic Fibrosis Based on Correlation Between "Collaterals and Vascular System" and Theory of "Hepatic Collateral Disease"
Discussion on Modern Development of Traditional Chinese Medicine Diagnosis Based on Artificial Intelligence
Related Author
TANG Yu
YANG Xuli
YANG Qiang
WANG Xiaojie
GAO Yongxiang
LI Xueping
ZHOU Jiafeng
WANG Meixia
Related Institution
Hospital of Chengdu University of Traditional Chinese Medicine
Lezhi County Hospital of Traditional Chinese Medicine
School of Basic Medical Sciences， Chengdu University of Traditional Chinese Medicine
The First Affiliated Hospital of Anhui University of Chinese Medicine
Graduate School，Anhui University of Chinese Medicine
Intro
Chat
